On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
50° Feels Like: 50°
Wind: WSW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 49°

Tomorrow

Mostly Sunny 73°

Wed Night

Partly Cloudy 53°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Novo Nordisk says completes hemophilia drug trial

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.

Novo Nordisk said in a statement that in patients given the drug, 99 percent of bleeding episodes were treated with only one infusion and two-thirds of the patients had experienced complete resolution of bleeding.

Patients had also reported an improvement in quality of life during the trial and the drug appeared to have a safe and well-tolerated profile, Novo said in the statement.

(Reporting by Copenhagen Newsroom; Editing by Anthony Barker)

Comments